IKBKB and breast carcinoma: To examine the contribution of IKKβ in osteoblasts and osteoclasts to breast cancer-osteolysis, we utilised the verified IKKβ inhibitors IKKβIII or IKKβV [28–30] together with a number of in vivo, ex vivo and in vitro experiments using immunocompetent mice, organs and cells.